BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2974478)

  • 1. Production of chemotactic factors for neutrophils following the interaction of Bacteroides gingivalis with purified C5.
    Schenkein HA; Berry CR
    J Periodontal Res; 1988 Sep; 23(5):308-12. PubMed ID: 2974478
    [No Abstract]   [Full Text] [Related]  

  • 2. Purification of human C5a des arg by immunoadsorbent and molecular sieve chromatography.
    Manderino GL; Suarez AF; Kunkel SL; Ward PA; Hirata AA; Showell H
    J Immunol Methods; 1982 Aug; 53(1):41-50. PubMed ID: 6752282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotaxin receptors on human neutrophils: modulation of C5a and peptide receptor number.
    Nelson RD; Chenoweth DE; Solomkin JS; Solem LD
    Agents Actions Suppl; 1983; 12():274-89. PubMed ID: 6301231
    [No Abstract]   [Full Text] [Related]  

  • 4. Attachment of human C5a des Arg to its cochemotaxin is required for maximum expression of chemotactic activity.
    Perez HD; Chenoweth DE; Goldstein IM
    J Clin Invest; 1986 Dec; 78(6):1589-95. PubMed ID: 3782473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The chemoattractant des-Arg74-C5a regulates the expression of its own receptor on a monocyte-like cell line.
    Barker MD; Jose PJ; Williams TJ; Burton DR
    Biochem J; 1986 Jun; 236(2):621-4. PubMed ID: 3019322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gc-globulin (vitamin D-binding protein) enhances the neutrophil chemotactic activity of C5a and C5a des Arg.
    Kew RR; Webster RO
    J Clin Invest; 1988 Jul; 82(1):364-9. PubMed ID: 3392213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the interaction of human C5a and C5a des Arg with human monocytes and neutrophils: flow cytometric and chemotaxis studies.
    Yancey KB; Lawley TJ; Dersookian M; Harvath L
    J Invest Dermatol; 1989 Feb; 92(2):184-9. PubMed ID: 2493055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotactic responses of human peripheral blood monocytes to the complement-derived peptides C5a and C5a des Arg.
    Marder SR; Chenoweth DE; Goldstein IM; Perez HD
    J Immunol; 1985 May; 134(5):3325-31. PubMed ID: 3884709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biologically active products of complement and acute lung injury in patients with the sepsis syndrome.
    Weinberg PF; Matthay MA; Webster RO; Roskos KV; Goldstein IM; Murray JF
    Am Rev Respir Dis; 1984 Nov; 130(5):791-6. PubMed ID: 6497161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human C5a and C5a des Arg exhibit chemotactic activity for fibroblasts.
    Senior RM; Griffin GL; Perez HD; Webster RO
    J Immunol; 1988 Nov; 141(10):3570-4. PubMed ID: 3183381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotactic peptides modulate adherence of human polymorphonuclear leukocytes to monolayers of cultured endothelial cells.
    Charo IF; Yuen C; Perez HD; Goldstein IM
    J Immunol; 1986 May; 136(9):3412-9. PubMed ID: 3514759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of two endogenous neutrophil-activating peptides in psoriatic skin and inflammatory cells: C5ades arg and NAP.
    Christophers E; Schröder JM; Mrowietz U
    Dermatologica; 1989; 179 Suppl 1():9-15. PubMed ID: 2673857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding characteristics of the complement peptides C3a and C5a-desArg to cellulose nitrate filters in Boyden chambers.
    Damerau B; Wüstefeld H; Vogt W
    Agents Actions Suppl; 1983; 12():121-33. PubMed ID: 6601363
    [No Abstract]   [Full Text] [Related]  

  • 14. Identification of C5ades arg and an anionic neutrophil-activating peptide (ANAP) in psoriatic scales.
    Schröder JM; Christophers E
    J Invest Dermatol; 1986 Jul; 87(1):53-8. PubMed ID: 3014008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The C5a receptor of neutrophils and macrophages.
    Chenoweth DE; Goodman MG
    Agents Actions Suppl; 1983; 12():252-73. PubMed ID: 6573117
    [No Abstract]   [Full Text] [Related]  

  • 16. [Humoral factors regulating leukocyte chemotaxis in peripheral blood].
    Podosinnikov IS; Turina OP
    Lab Delo; 1984; (7):410-4. PubMed ID: 6207347
    [No Abstract]   [Full Text] [Related]  

  • 17. Polymorphonuclear leukocyte chemotaxis in systemic lupus erythematosus.
    Perez HD; Goldstein IM
    J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():53-8. PubMed ID: 3612652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the C5a des Arg cochemotaxin. Homology with vitamin D-binding protein (group-specific component globulin).
    Perez HD; Kelly E; Chenoweth D; Elfman F
    J Clin Invest; 1988 Jul; 82(1):360-3. PubMed ID: 3392212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of neutrophil migratory function in burn injury by complement activation products.
    Solomkin JS; Nelson RD; Chenoweth DE; Solem LD; Simmons RL
    Ann Surg; 1984 Dec; 200(6):742-6. PubMed ID: 6508405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diverging effects of chemotactic serum peptides and synthetic f-Met-Leu-Phe on neutrophil locomotion and adhesion.
    Keller HU; Wissler JH; Damerau B
    Immunology; 1981 Mar; 42(3):379-83. PubMed ID: 7203527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.